BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 19, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Oct. 26, 2015

View Archived Issues

Inside the Beltway: FDA eyes injection practices in draft for syringes and vials

Read More

2015 Bio Investor Forum: With targets aplenty, precision medicine seeks precise path forward

Read More

French Radiology Conference: France struggles to keep pace with ambitious goals for imaging

Read More

Financings: Sequana raises CHF 9 million in series C extension round

Read More

MDD Stock Report for Public Med-tech Companies

Read More

Court Report: Nuvasive loses out on patent lawsuit against Medtronic

Read More

Agreements/contracts: Edwards collaborates with Carefusion in IV administration

Read More

U.S. Ortho Market picks up Speed: Stryker beats EPS expectations for the quarter, continues sales growth streak

In line with U.S. orthopedic trends spotted across the market, Stryker (Kalamazoo, Mich.) has delivered a minimum of 5 percent organic sales growth for the tenth consecutive quarter, although weak international sales did drag growth to 5.3 percent compared to the 6.9 percent growth Stryker reported in the second quarter. Kevin Lobo, Stryker's chairman/CEO, said all three business segments delivered year-over-year sales growth during the third quarter, driven by strong U.S. momentum and the company's diversified model. Read More

NewCo on the Go: Blaze sets focus on technology to detect red blood cell damage

Read More

Patent Watch: Fluoresentric awarded patent protection for XCR technology

Read More

People in Places

Read More

Briefly Noted

Read More

product briefs

Read More

MDD's Neurology Extra

Read More

M&A values nearly double in 3Q15 across fewer deals versus 3Q14

Read More

Med-tech firms bring in nearly $1.4B in funding for 3Q15

Read More

Ubl leaves AdvaMed to become new CEO at PhRMA

Read More

Down a tick, innovation in med-tech continues to thrive

Read More

Popular Stories

  • Today's news in brief

    BioWorld

    BioWorld briefs for March 19, 2026.

  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 17, 2026
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing